AJANTA STAMINA COMBINATION PRODUCT CAPSULE

Indications

• Allergic rhinitis
• Urticaria
• Allergic conjunctivitis
• Anaphylactic reactions (as adjunct therapy)
• Motion sickness (in some formulations)

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations tailored to pediatric populations.

Adults: Refer to the specific product information and local guidelines for appropriate dosage, as it may vary by formulation.

Mechanism of action

Badastar acts as a selective antagonist of the H1 histamine receptor. By binding to these receptors, it prevents histamine from exerting its effects, thus alleviating symptoms of allergies. Additionally, it may exert some anti-inflammatory effects by reducing the release of pro-inflammatory mediators from mast cells.

Pharmacodynamics

The pharmacodynamics of Badastar involve the modulation of allergic responses through H1 receptor blockade. This results in reduced vascular permeability, decreased mucus secretion, and inhibition of pruritus (itching). The onset of action typically occurs within 1 to 2 hours, with effects lasting for several hours, depending on the specific formulation and dosage.

Pharmacokinetics

Badastar is well-absorbed from the gastrointestinal tract after oral administration. It undergoes extensive hepatic metabolism, primarily via cytochrome P450 enzymes. The elimination half-life varies among individuals but is generally in the range of 6 to 15 hours. Excretion occurs mainly via the urine, with a small proportion eliminated in feces. The drug's pharmacokinetic profile may be affected by factors such as age, liver function, and co-administration of other medications.

Pregnancy

Data on the safety of badastar during pregnancy is limited. It is recommended to weigh potential benefits against potential risks.

Breast-feeding

The excretion of badastar in human milk is unknown. Caution is advised when administering to breastfeeding women.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Dosage

Children: Refer to specific dosing guidelines for the individual substance in question, as there is no standard dosage for the term 'bang.'

Adults: Refer to specific dosing guidelines for the individual substance in question, as there is no standard dosage for the term 'bang.'

Mechanism of action

The mechanism of action for substances referred to as 'bang' can vary significantly based on the specific substance in question. Often, stimulant drugs work by increasing the levels of neurotransmitters such as dopamine and norepinephrine in the brain, leading to enhanced alertness, increased energy, and euphoria. More specific pathways would depend on the exact compound.

Pharmacodynamics

The pharmacodynamics of stimulant substances typically involve the stimulation of the central nervous system. This can lead to increased heart rate, elevated blood pressure, and enhanced mood. The effects can vary greatly depending on the substance, dosage, and the individual's physiological response.

Pharmacokinetics

Pharmacokinetics will differ based on the specific compound. Generally, stimulant drugs may be rapidly absorbed into the bloodstream, with peak effects occurring shortly after administration. Metabolism often takes place in the liver, and elimination may occur through urine, with half-lives varying widely among different substances.

Pregnancy

Not enough data available to determine safety during pregnancy. Use with caution and only if clearly needed.

Breast-feeding

Not enough data available to determine safety during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Inflammation
• Pain relief
• Antioxidant support

Dosage

Children: Refer to professional guidelines or consult a qualified healthcare provider for appropriate dosing.

Adults: Refer to professional guidelines or consult a qualified healthcare provider for appropriate dosing.

Mechanism of action

The precise mechanism of action of Bhasna is not well-defined in scientific literature; however, it is thought to modulate inflammatory pathways and enhance antioxidant defenses in the body. Compounds found in Bhasna may exert effects on signaling pathways related to inflammation and oxidative stress, potentially leading to relief from pain and inflammation.

Pharmacodynamics

Bhasna exhibits anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines and mediators, thereby reducing inflammation. Additionally, its antioxidant properties help to neutralize free radicals, contributing to cellular protection and overall health improvement.

Pharmacokinetics

The pharmacokinetics of Bhasna are not well-characterized in clinical studies. Generally, herbal compounds may be absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via the kidneys. The bioavailability and half-life of specific active components may vary depending on the formulation and individual patient factors.

Pregnancy

Safety in pregnancy has not been established. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if bhasna is excreted in human milk. Caution should be exercised when administered to breastfeeding women.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Osteoarthritis
• Rheumatoid arthritis
• Asthma
• Ulcerative colitis
• Crohn's disease
• Inflammatory bowel disease
• Anxiety
• Stress-related disorders

Dosage

Children: Paediatric dosing should be determined by a healthcare professional based on the child's age, weight, and specific condition.

Adults: Dosage for adults varies based on the condition being treated and the formulation used. It is advisable to follow product-specific guidelines or consult a healthcare professional for dosing recommendations.

Mechanism of action

The primary mechanism of action of fragrans involves the inhibition of pro-inflammatory mediators and enzymes such as 5-lipoxygenase, which plays a role in the production of leukotrienes. Boswellic acids, the main active components, inhibit the synthesis of these inflammatory mediators, thereby reducing inflammation and pain. Additionally, these compounds may modulate immune responses and have antioxidant effects.

Pharmacodynamics

Fragrans exhibits anti-inflammatory and analgesic effects, making it beneficial in the management of inflammatory conditions such as arthritis and asthma. The anti-inflammatory activity is thought to result from its ability to inhibit leukotriene biosynthesis. Furthermore, the resin may have mood-enhancing properties when used in aromatherapy, potentially due to its effects on the central nervous system and limbic system.

Pharmacokinetics

Fragrans is typically administered through oral, topical, or inhalation routes. Following administration, the active components are absorbed into the bloodstream, where they exert systemic effects. The bioavailability of boswellic acids can vary depending on the formulation and route of administration. Metabolism primarily occurs in the liver, with excretion primarily via the kidneys. The pharmacokinetic profile can be influenced by factors such as the presence of food and specific formulations.

Pregnancy

Insufficient data on safety in pregnancy. Caution is advised.

Breast-feeding

Limited information available. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Dosage

Children: Refer to established clinical guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established clinical guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The precise mechanism of action for Jund is not well documented. Generally, compounds in this category may act by modulating neurotransmitter levels, influencing receptor activity, or altering enzyme pathways to achieve their therapeutic effects. Further research is needed to elucidate the exact mechanisms.

Pharmacodynamics

The pharmacodynamics of Jund involves its interaction with biological systems, leading to therapeutic effects such as the modulation of physiological responses. This may include alterations in pain perception, immune response, or metabolic processes, depending on its specific class and intended use. The efficacy and safety profile would depend on the dose and duration of therapy.

Pharmacokinetics

Pharmacokinetics details how Jund is absorbed, distributed, metabolized, and excreted in the body. Due to insufficient data, specific parameters such as bioavailability, half-life, and clearance rates are not available. Generally, pharmacokinetic properties influence the drug's therapeutic window and dosing regimen.

Pregnancy

The safety of jund during pregnancy has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether jund is excreted in human breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct light. Keep out of reach of children.

Indications

• Parkinson's disease
• Restless legs syndrome
• Mood enhancement
• Improvement of sexual function
• Neuroprotection

Dosage

Children: Refer to established clinical guidelines and consult healthcare professionals for specific dosing information based on the condition being treated.

Adults: Refer to established clinical guidelines and consult healthcare professionals for specific dosing information based on the condition being treated.

Mechanism of action

Mucuna pruriens exerts its effects primarily through its high concentration of L-DOPA, which is converted into dopamine in the brain. Dopamine is a critical neurotransmitter involved in the regulation of mood, motor control, and reward pathways. Additionally, Mucuna may influence other neurotransmitters and hormones, potentially enhancing overall mental well-being and physical performance.

Pharmacodynamics

The pharmacodynamic effects of Mucuna pruriens are attributed mainly to L-DOPA. By increasing dopamine levels, it can help alleviate symptoms associated with dopamine deficiency, such as those seen in Parkinson's disease. The herb may also exert mood-lifting effects and improve cognitive function. Its antioxidant properties may contribute to neuronal protection against oxidative stress.

Pharmacokinetics

Mucuna pruriens, when consumed, is absorbed in the gastrointestinal tract. L-DOPA is rapidly absorbed and crosses the blood-brain barrier, where it is converted to dopamine. The onset of action can vary based on the formulation and individual metabolism, with effects generally noticed within a few hours. The elimination half-life of L-DOPA is approximately 1 to 3 hours, and it is metabolized primarily in the liver.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Insomnia
• Anxiety
• Hallucinations

Interactions

• Antidepressants
• Dopamine agonists
• Levodopa

Precautions

• Use with caution in patients with a history of psychosis
• Monitor for signs of excessive dopamine activity
• Not recommended for use in individuals with cardiovascular disorders

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and the potential benefits outweigh the risks.

Breast-feeding

Safety during breastfeeding has not been established. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsules
• Tablets

Indications

• Digestive disorders
• Nausea
• Pain relief
• Anti-inflammatory conditions
• Mood enhancement

Dosage

Children: Pediatric dosing information is not well established. It is recommended to consult healthcare professionals for appropriate dosing based on age

Adults: Dosage can vary widely based on the form of administration and the intended effect. Generally, culinary uses involve small amounts of ground nutmeg. For medicinal purposes, it is advisable to consult specific guidelines or healthcare professionals.

Mechanism of action

The primary active compounds in Myristica, particularly myristicin, are thought to exert their effects through modulation of neurotransmitter systems, particularly in the central nervous system. Myristicin may inhibit the enzyme monoamine oxidase, leading to increased levels of neurotransmitters such as serotonin and dopamine. This mechanism may contribute to its psychoactive effects, while other compounds like eugenol exhibit anti-inflammatory and analgesic properties through inhibition of cyclooxygenase enzymes.

Pharmacodynamics

Myristica exhibits various pharmacodynamic effects, including anti-inflammatory, analgesic, and potential psychoactive actions. The compounds found in nutmeg may influence mood and cognition, though these effects are dose-dependent and can lead to toxicity at higher doses. Myristica may also enhance digestive processes and reduce gastrointestinal discomfort due to its carminative properties.

Pharmacokinetics

The pharmacokinetics of Myristica and its active components are not extensively studied, but it is known that the bioavailability of myristicin and other compounds can be affected by their metabolic pathways. After ingestion, these compounds undergo hepatic metabolism, primarily through cytochrome P450 enzymes. The half-life and elimination pathways are not well-defined, and effects can vary significantly among individuals due to differences in metabolism and sensitivity to the psychoactive properties.

Pregnancy

Myristica is not well-studied in pregnant women; caution is advised.

Breast-feeding

There is insufficient data on the safety of Myristica during breastfeeding; it is recommended to consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Parkinson's disease
• Mood enhancement
• Sexual dysfunction
• Stress management
• Neuroprotection

Dosage

Children: Refer to specific product guidelines for dosing information.

Adults: Refer to specific product guidelines for dosing information.

Mechanism of action

Mucuna pruriens exerts its effects primarily through the conversion of L-DOPA to dopamine in the brain. This increase in dopamine levels can help alleviate symptoms of Parkinson's disease and improve mood. The presence of other bioactive compounds such as antioxidants and alkaloids may also contribute to its adaptogenic properties, helping the body manage stress and improve overall well-being.

Pharmacodynamics

The pharmacodynamics of Mucuna pruriens is largely attributed to its ability to increase central nervous system dopamine levels. This action can lead to improved motor control and reduced symptoms of bradykinesia and rigidity in Parkinson's disease patients. Additionally, the herb may enhance mood and cognitive function by modulating neurotransmitter levels, particularly in stressful situations.

Pharmacokinetics

The pharmacokinetics of Mucuna pruriens are influenced by its route of administration and the presence of food. After ingestion, L-DOPA is absorbed in the gastrointestinal tract and transported across the blood-brain barrier, where it is converted to dopamine. The peak plasma concentration typically occurs within 1 to 2 hours. The elimination half-life of L-DOPA is approximately 1.5 to 2 hours, and it is primarily metabolized in the liver and excreted in urine. Individual variations in metabolism can affect the duration and intensity of the drug's effects.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Headache
• Dizziness
• Insomnia
• Anxiety

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Monitor for potential interactions with CNS depressants
• Caution in patients with psychiatric conditions

Pregnancy

Insufficient data on safety during pregnancy; use only if clearly needed and after assessing risks versus benefits.

Breast-feeding

Limited information available; exercise caution and consult healthcare provider.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Formulations

• Powdered extract
• Capsules
• Tablet form
• Tincture

Indications

• Fatigue
• Cognitive enhancement
• Nutrient absorption improvement
• Joint health
• Stress management

Dosage

Children: There is limited information on the use of Silajeet in children. Consult a healthcare professional for appropriate dosing and safety considerations.

Adults: Dosage for adults can vary based on the formulation and intended use. It is recommended to refer to specific product guidelines or consult a healthcare professional for appropriate dosing information.

Mechanism of action

Silajeet is believed to exert its effects through several mechanisms. The fulvic acid component enhances the bioavailability of nutrients and minerals, facilitating their absorption in the body. It also acts as an antioxidant, protecting cells from oxidative stress. Furthermore, Silajeet may influence mitochondrial function, enhancing ATP production and energy metabolism, thus improving physical performance and reducing fatigue.

Pharmacodynamics

Silajeet demonstrates various pharmacodynamic properties, including antioxidant, anti-inflammatory, and adaptogenic effects. Its antioxidant properties help scavenge free radicals, reducing cellular damage. The anti-inflammatory effects may contribute to improved joint health and reduced symptoms of arthritis. Additionally, the adaptogenic properties may help the body adapt to stress, promoting overall mental and physical well-being.

Pharmacokinetics

The pharmacokinetics of Silajeet are not extensively studied. However, it is generally believed that the fulvic acid in Silajeet enhances the absorption of its active compounds through the gastrointestinal tract. The onset of action may vary depending on the formulation and individual metabolism. It is typically administered orally, and the effects can be seen over a period of time with consistent use.

Adverse effects

• Gastrointestinal upset
• Headache
• Dizziness
• Fatigue
• Allergic reactions

Interactions

• Potential interaction with anticoagulants
• May affect blood pressure medications
• Possible interaction with antidiabetic agents

Precautions

• Use with caution in individuals with diabetes
• Monitor for potential allergic reactions
• Consult healthcare provider if taking other medications

Pregnancy

Limited data available, consult a healthcare provider before use.

Breast-feeding

Limited data available, consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extract

Indications

• Anxiety
• Stress management
• Insomnia
• Cognitive enhancement
• General well-being

Dosage

Children: Refer to specific product guidelines for dosing. Pediatric dosing should be approached with caution and under professional guidance.

Adults: Refer to specific product guidelines for dosing. Dosages may vary based on the formulation and condition being treated.

Mechanism of action

Somnifera is believed to exert its effects through modulation of the hypothalamic-pituitary-adrenal (HPA) axis and reduction of cortisol levels. It may enhance the activity of gamma-aminobutyric acid (GABA) at the GABA receptors, contributing to its anxiolytic effects. Additionally, it may influence neurotransmitter systems, including serotonin and dopamine, promoting a balanced mood and mental clarity.

Pharmacodynamics

Somnifera exhibits a range of pharmacological effects including anti-anxiety, anti-stress, and antidepressant properties. Its adaptogenic properties help in enhancing physical and mental performance under stress. The herb has also been shown to possess anti-inflammatory and antioxidant effects, which may contribute to overall health benefits.

Pharmacokinetics

The active compounds in Somnifera, such as withanolides, are absorbed in the gastrointestinal tract. Peak plasma concentrations are generally reached within a few hours post-administration. The metabolism of these compounds is primarily through hepatic pathways, and they are excreted via urine and feces. The half-life of the active constituents can vary based on dosage and formulation.

Adverse effects

• Drowsiness
• Dizziness
• Gastrointestinal upset
• Allergic reactions

Interactions

• May potentiate the effects of sedatives and hypnotics
• Potential interaction with alcohol leading to increased sedation

Precautions

• Use with caution in patients with a history of allergies
• Monitor for excessive sedation
• Caution in patients with respiratory conditions

Pregnancy

Insufficient evidence on safety, use with caution.

Breast-feeding

Limited data, use with caution and consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered root
• Capsules
• Tablets
• Tinctures

Indications

• Stress management
• Anxiety
• Depression
• Cognitive enhancement
• Physical performance improvement
• Anti-inflammatory conditions

Dosage

Children: Consult the BNF for Children for appropriate dosing information.

Adults: Dosage can vary by formulation, typically ranging from 300 mg to 600 mg of standardized extract per day, divided into two doses.

Mechanism of action

Withania acts through multiple mechanisms, including modulation of the hypothalamic-pituitary-adrenal (HPA) axis, which helps regulate the body's stress response. It may also influence the levels of neurotransmitters such as serotonin and gamma-aminobutyric acid (GABA), promoting an anxiolytic effect. Additionally, withanolides have been shown to interact with various cellular pathways, including those involved in inflammation and apoptosis.

Pharmacodynamics

Withania exhibits adaptogenic properties, aiding in the stabilization of physiological processes and promoting homeostasis. Its anti-inflammatory effects are attributed to the inhibition of pro-inflammatory cytokines and pathways, thus reducing oxidative stress. It also enhances cognitive function and physical performance, potentially via neuroprotective effects on neuronal cells.

Pharmacokinetics

The pharmacokinetics of Withania are characterized by its bioactive compounds being rapidly absorbed and distributed in the body. Withanolides are metabolized by the liver and excreted primarily through urine. The half-life of these compounds can vary, influencing dosing intervals and therapeutic effects. The variations in absorption and metabolism can be influenced by formulation and individual patient factors.

Adverse effects

• Gastrointestinal upset
• Drowsiness
• Headache
• Hypotension

Interactions

• May enhance the effects of sedatives and other CNS depressants
• Potential interaction with thyroid medications
• May affect blood sugar levels, caution with antidiabetic drugs

Precautions

• Use with caution in individuals with autoimmune diseases
• Monitor blood sugar levels in diabetic patients
• May cause drowsiness; caution when driving or operating heavy machinery

Pregnancy

Insufficient data on safety in pregnancy; use with caution.

Breast-feeding

Limited data available; consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered root
• Capsules
• Liquid extract
• Tincture